Your browser is no longer supported. Please, upgrade your browser.
Settings
IBB iShares Nasdaq Biotechnology ETF daily Stock Chart
IBB [NASD]
iShares Nasdaq Biotechnology ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.80%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month8.83%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter14.64%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y16.23%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year15.68%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range89.01 - 121.16 Perf YTD24.55%
Dividend0.16 P/FCF- EPS past 5Y- ROI- 52W High-0.87% Beta-
Dividend %0.13% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low34.93% ATR1.68
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)73.54 Volatility1.41% 1.37%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.70 Prev Close119.41
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume2.39M Price120.10
Recom- SMA203.86% SMA5010.76% SMA20012.21% Volume1,663,991 Change0.58%
Dec-10-19 04:16PM  Why Biotech ETFs are Surging to New Highs Zacks
10:10AM  Biotech ETFs Hit New Highs on Deal Activities Zacks
Dec-06-19 01:00PM  Is Trade Scaring You? ETF Strategies for 2019 Holiday Season Zacks
Dec-05-19 07:18AM  Sage Therapeutics's stock plunges after depression treatment study fails primary endpoint MarketWatch
Dec-04-19 07:45PM  Healthy Bounce Investopedia
04:53PM  Trade of the 2020's: Sell Gold, Buy Biotech Zacks
Dec-03-19 02:29PM  Aslan Pharmaceuticals stock plunges after stock offering prices at a 52% discount MarketWatch
Dec-02-19 02:40PM  A Guide to Biotech ETF Investing Zacks
01:34PM  Aslan stock pares its big gain after announcing stock offering MarketWatch
07:51AM  Aslan Pharmaceuticals' stock soars on heavy volume, after rocketing nearly 9-fold the past week MarketWatch
Nov-29-19 06:45AM  Biotechnology ETF (IBB) Hits New 52-Week High Zacks
Nov-27-19 05:33PM  Why Gold is Headed to Zero -- And What You Should Buy Instead Zacks
06:52AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Nov-26-19 07:06PM  Why Biotech ETFs Surged in Monday's Trading Session Zacks
Nov-25-19 11:03AM  Biotech ETF Rally Not Yet Luring Investors ETF Trends
10:06AM  Biotech Stocks Awaken From Long Slumber Investopedia
Nov-22-19 08:28AM  Biotech Stock Funds Just Arent Getting a Break From Outflows Barrons.com
Nov-21-19 08:04AM  Hepion Pharmaceuticals' stock rockets after upbeat results of preclinical study of liver cirrhosis treatment MarketWatch
Nov-18-19 11:18AM  Karuna Therapeutics' stock more than triples after upbeat trial results of schizophrenia treatment MarketWatch
Nov-12-19 11:55AM  Top-Ranked ETFs That Crushed the Market in a Month Zacks
10:10AM  Follow Morgan Stanley to Trade 2020 Election With ETFs Zacks
Nov-11-19 11:40AM  89bio's stock surges in public debut, as stock opens 25% above IPO price MarketWatch
07:06AM  Lipocine's stock plummets after receiving CRL from FDA for testosterone deficiency treatment MarketWatch
Nov-08-19 02:58PM  The Unloved Biotechnology ETF Rally ETF Trends
Nov-07-19 11:34AM  Zacks Market Edge Highlights: XLK, IBB, Square, SOXX and Amazon Zacks
Nov-06-19 12:43PM  Our Favorite Investing Lessons from the Last 20 Years Zacks
Nov-05-19 08:32AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Nov-04-19 05:05PM  Biotech ETFs in Focus on Impressive Q3 Earnings Results Zacks
Nov-01-19 08:00AM  Healthcare ETFs Are The Top Performers for October ETF Database
Oct-31-19 01:11PM  Agile Therapeutics' stock rockets nearly 4-fold after contraceptive patch Twirla gets favorable FDA committee nod MarketWatch
04:30AM  8 Undervalued Biotech Stocks to Watch Now Investopedia
Oct-30-19 09:24AM  Cyclerion's stock plummets to pace premarket losers after diabetes treatment study missed primary endpoint MarketWatch
Oct-29-19 04:05PM  Experts Talk Hot Biotech Stocks at Barrons Breakfast Barrons.com
Oct-28-19 08:00AM  Biotech ETF Rallies on Alzheimer Treatment Report ETF Database
Oct-25-19 09:51AM  Biotech Fund Investors Are Fleeing, but Biogen Stock and Others Are Rising Barrons.com
Oct-24-19 11:47AM  How to invest in biotech stocks like a Nobel Prize winner MarketWatch
Oct-23-19 04:24PM  Navigating The Healthcare Industry: Science Fiction Turns to Reality Zacks
Oct-17-19 08:28AM  Hepion Pharmaceuticals stock soars premarket-leading volume after positive data on liver disease treatment MarketWatch
Oct-16-19 07:15AM  Achillion Pharmaceuticals' stock rockets after Alexion Pharmaceuticals $930 million buyout deal MarketWatch
Oct-14-19 10:16AM  The Biotech Sector Is Lagging. Blame Gene Therapy Stocks, Analysts Say. Barrons.com
Oct-11-19 10:45AM  VC Money Is Flowing Into Biotechs Benzinga
Oct-03-19 10:11AM  3 Healthcare Stocks to Watch for the Long Run TipRanks
Sep-27-19 04:34PM  Getting TECHNICAL: Bonds signalling more factor rotation into October Yahoo Finance Video
Sep-25-19 10:36AM  Adding Biotech ETFs to Your Portfolio Investopedia
Sep-20-19 11:04AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Sep-18-19 01:01PM  Sell on the Pop Prospects: September 18 Edition ETF Database
Aug-29-19 07:39AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Aug-27-19 10:05AM  Amgen to Buy Celgene's Otezla: 5 ETF Drugs Zacks
Aug-20-19 01:06PM  8 Biotech Stocks to Watch After the Q2 Earnings Season InvestorPlace
Aug-07-19 06:45AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Aug-06-19 04:22PM  Biotech ETFs in Focus on Impressive Q2 Earnings Results Zacks
Aug-03-19 10:18AM  The Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts Benzinga
Jul-26-19 12:04PM  4 Biotech Stocks Sliding Lower InvestorPlace
Jul-16-19 07:01AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Jul-15-19 08:45AM  Capicor Therapeutics' stock rockets on heavy volume after positive MD trial results MarketWatch
Jul-09-19 05:10PM  Biotech ETFs Strengthen After Judge Blocks Trumps Drug Pricing Rule ETF Trends
04:18PM  Drug Pricing War: Pharma, Biotech Stocks Score A Win Over Trump Investor's Business Daily
07:15AM  Altimmune's stock soars after adding NASH candidate with purchase of Spitfire Pharma MarketWatch
Jul-05-19 09:46AM  Tyme Technologies stock soars on heavy volume after upbeat update to cancer treatment study MarketWatch
Jul-03-19 08:21AM  Unum Therapeutics stock plunges toward record low after FDA places 'clinical hold' on trial MarketWatch
Jul-02-19 07:42AM  Incyte enters license pact with Zai Lab to commercialize its cancer treatment in Greater China MarketWatch
Jun-26-19 09:31AM  Adaptive Biotechnologies to sell more shares in IPO, as expected pricing increases MarketWatch
Jun-25-19 09:33AM  Despite Recent Volatility, Biotech Stocks Look Poised to Pop Investopedia
09:24AM  The Rush to Biotech ETFs Is Back On (IBB, XBI) Investopedia
Jun-21-19 09:15AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
07:31AM  ContraVir's stock rockets off record low after 'positive feedback' on pre-IND for NASH MarketWatch
Jun-17-19 01:31PM  Adaptive Biotechnologies sets terms for IPO, to raise up to $212.5 million MarketWatch
01:17PM  Karuna Therapeutics sets IPO terms, to be valued at up to $363 million MarketWatch
Jun-14-19 09:50AM  Morphic Holding sets terms of IPO to raise up to $80 million MarketWatch
07:48AM  Kura Oncology's stock soars toward record high after trial of lymphoma treatment achieves goal MarketWatch
Jun-13-19 07:27AM  Provention Bio's stock surges after calling off public stock offering MarketWatch
Jun-12-19 06:29AM  Barclays Has New Plays for Healthcare Fans SmarterAnalyst
Jun-07-19 08:56AM  Cancer genomics company Personalis expects to raise up to $107 million in IPO MarketWatch
07:48AM  Stoke Therapeutics to raise up to $107 million in IPO MarketWatch
Jun-04-19 11:07AM  Biotech Sector Could Enter Bear Market Investopedia
May-30-19 06:53AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
May-23-19 01:21PM  Ideaya Biosciences' stock opened 40% above its IPO price, then pared most of its gains MarketWatch
May-20-19 09:02AM  Outlook Therapeutics stock rockets on heavy volume again, set to triple in 3 days MarketWatch
May-17-19 09:47AM  Outlook Therapeutics' stock rockets on heavy volume again, has more than doubled in 2 days MarketWatch
May-15-19 06:55AM  Foamix (FOMX): A Beaten-Down Biotech Stock That Looks Like a Bargain Now SmarterAnalyst
May-13-19 10:54PM  Reaping the Benefits of In-Depth Knowledge of ETFs Insider Monkey
02:15PM  FDA Issues Final Guidelines To Make Interchangeable Biosimilars More Easily Available Benzinga
May-09-19 07:46AM  These 3 revolutionary genomics companies are changing lives for patients and investors MarketWatch
May-07-19 04:57PM  Biotech ETFs in Focus on String of Q1 Earnings Beats Zacks
May-02-19 01:21PM  These 6 biotech stocks are promising takeover targets MarketWatch
Apr-30-19 01:00PM  Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Benzinga
10:39AM  Axcella Health sets IPO terms, which could value the biotech at up to $505.7 million MarketWatch
Apr-26-19 02:01PM  Gilead Stock Is Due for a Comeback, Analyst Says Barrons.com
Apr-25-19 01:26PM  Can Health Care Recover from Medicare for All? Harvest Exchange
Apr-24-19 04:04PM  Will Biotech ETFs Continue to Rally in Q1 Earnings? Zacks
Apr-19-19 09:27AM  Health-care drama has now spread to biopharma stocks MarketWatch
Apr-18-19 12:17PM  Intuitive Surgical Stock Is Down but Not Out InvestorPlace
07:00AM  Mustang Bio's stock soars to near 4-fold gain after deal to commercialize 'bubble boy' disease treatment MarketWatch
Apr-15-19 01:49PM  ImmunoGen Stock Is in Trouble Going Into Earnings InvestorPlace
10:46AM  Bio-Path's stock rockets after withdrawal of stock offering MarketWatch
Apr-12-19 08:16AM  Biotech company Axcella Health files for IPO MarketWatch
07:23AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Apr-10-19 04:44PM  Global X Launches GNOM ETF to Tap Booming Genomics Space Zacks
11:11AM  Is AstraZeneca Stock Worth Buying Before Earnings? InvestorPlace
Apr-08-19 03:09PM  Concert Pharmaceuticals' stock takes a sharp dive after disappointing patent appeal board ruling MarketWatch
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.